Updated 04:19 GMT, 16 Nov 2026 SPX 7,561.67 -0.40% NDX 27,943.74 -1.22% VIX 19.30 +3.21% GOLD 3,873.60 -0.33% CL 88.49 -0.08% BTC 64,896.46 +1.20%
NAS100 27,944 −1.22% S&P 7,562 −0.40% GOLD $3,874 −0.33% BTC $64,896 +1.20% VIX 19.30 +3.21% latest tape · as of 04:19 UTC
The Screen · Consumer Defensive · Food Distribution

Mission Produce, Inc.

AVO · Nasdaq · USD · Market cap $1.0B · 3,800 employees

Mission Produce, Inc.

PASS · Titan Ethical · score 70.0
11.83 USD

Price as of 13 Nov 2026Daily close, not a live quote

Screened 2026-11-13 · the tape above runs as of 04:19 UTC · two dates, stated on purpose · verdict and workings shown in full · never trimmed

Key facts today

  • Price11.83 USD at the 13 Nov 2026 close
  • Our value readUndervalued vs our fair value, as of 13 Nov 2026
  • Our regime readDistribution, as of 15 Nov 2026
  • Ethical screenPasses, score 70.0 out of 100
  • OptionsOpen interest leans heavily to calls (put/call 0.15)
  • Last reviewed13 Nov 2026 (3 days ago)
  • Release timesRelease and earnings times on your chart: Event Guard Mentor

A summary of the dated readings below, not a live quote and not advice.

PRICE · ONE YEAR

Our fair-value range: $13.50 to $19.90, base estimate $15.96 (screen dated 2026-11-13).

Current read
Distribution ?
Undervalued · screened 2026-11-13
  • Trend Distribution
  • Insiders insiders bought, latest filing 2026-10-09
  • Positioning no disclosures inside 60 days, left as found
  • Options put/call open interest 0.15, read 2026-11-15
  • Ethical passes the values gate
Price11.83 USD
Fair value15.96
Ethical score70.0/100
Value readUndervaluedas of 13 Nov 2026
Our investment reviews on this name
2026-11-08Read Distribution11.66+1.5% to today Markdown gives way to Distribution
2026-11-01Read Markdown11.50+2.9% to today Distribution gives way to Markdown after an 8% slide in 3 weeks
2026-10-11Read Distribution12.51-5.4% to today ✓Accumulation gives way to Distribution
2026-09-05Read Accumulation12.82-7.7% to today Markup gives way to Accumulation

Our analytic regime reads on this name, dated and marked against the screened price. Small sample per name, and separate from the daily-framework accuracy on the Track Record page.

The full research record, in depth, below
The Label · The Season, Not the Day

This name holds its distribution label.

Mission Produce, Inc. holds its Distribution at $11.83. The statistical read favours the buyers, held for 7 days.

As held on the ledger · 2026-11-13
PhaseDistribution · caution
Quantitative stateThe statistical read favours the buyers, held for 7 days
Price at the screen$11.83
Valuation383.67 trailing · 14.46 forward price to earnings
Values screenPASS · score 70.0
Beta0.44
The Workings

Five Screens, Shown in Full

Full pass across all five screens. This security clears the Titan Ethical Standard: its business and its balance sheet both stay inside the lines.

TestFigureLimitWhat it meansStatus
Business activity Permissible Core business clean Its core business isn't built on prohibited lines: no gambling, alcohol, tobacco, weapons, or interest-based lending. Pass
Debt load 20.44% Below 33% Interest-bearing debt is just 20.4% of its assets, well under the one-third ceiling: it does not run on borrowed money. Pass
Interest-bearing cash 0.00% Below 33% Cash held in interest-bearing accounts and securities is 0.0% of assets, under the one-third limit. Pass
Receivables 14.78% Below 49% Money owed to the company is 14.8% of assets, under the 49% limit. Pass
Revenue purity 0.12% Below 5% Only 0.1% of revenue comes from non-compliant sources, under the 5% line. Pass

Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.

The Ethical Read

Why It Clears, in Plain English

Mission Produce, clears all five screens. Its business is in a permissible area, its interest-bearing debt is about 20%, inside the ~33% line, and almost none of its income is interest, so it passes.

Read as at 2026-11-14. It updates when the underlying figures move, and past reads are kept below.

Follow this verdict

Get an email when AVO's ethical verdict changes

Today AVO passes the screen. If new figures move it to a fail, we send you one short email with the before and after. Verdicts change rarely, so you may not hear from us for a long time.

Free, no account needed. Every email has a link to stop.

What the Numbers Say It Is Worth

The Fair Value Range

Our analysis reads Undervalued vs our fair value, as of 13 Nov 2026: it trades at roughly a 26% discount to our $15.96 fair value, 25.80% revenue growth.

How a fair value is estimated: discounted cash flow (DCF).

13.50Conservative15.96Base case19.90Growth case 11.83Price

Fair value range in USD, drawn from the 2026-11-13 screen. The gold marker is the market price at the same screen. A 25.9% discount to the base estimate.

The Street's Range
15.00Street low 16.00Street average 18.00Street high 11.83Price

Third-party analyst targets. The average target sits +35% from the screen price.

Reading the gap · Both our model and the analysts see meaningful upside from here.

Price History & Projections

Where our models see it going: fair-value estimate $15.96, with a range of $13.50 to $19.90, dated to the 2026-11-13 screen.

Fair value and rating are our own model estimates; the Street's range reflects third-party analyst estimates. Analysis, not advice.

The Business, in Plain Words

Avocados look cheap but growth has vanished

Picture a fruit trader whose sales just dropped a quarter while margins sit at two percent. Mission Produce moves avocados and mangoes to supermarkets and restaurants, yet revenue is down 24 percent and return on equity is only 4 percent. The shares trade at 16.3 times forward earnings with a 22 percent gap to our fair value, but those numbers sit on a business that is shrinking rather than compounding.

We pass because the low return and negative growth point to a company stuck in a tough patch with no clear path out. A 16 times multiple is not a bargain when earnings are already thin and volume trends are negative. The ethical screen clears, yet the operating record does not meet the bar we set for owning a position.

Four analysts still call it a strong buy with a 16 dollar target. We see a classic value trap where the multiple looks reasonable only because profits have already fallen. Analysis, not advice.

The fundamentals · plain-English read
Forward P/E14.5xcheap for a company growing this fast
Trailing P/E383.7xexpensive: the price assumes strong growth ahead
EPS, trailing0.03
EPS, forward0.80
Revenue growth+25.8%strong top-line growth
Profit margin0.1%barely profitable
Return on equity0.5%a modest return on shareholder capital
FCF yield-3.09%
Debt to equity0.65moderate, manageable leverage
Current ratio1.92healthy short-term liquidity
Beta0.44barely tracks the market's swings
Short interest, float0.09%
52-week range10.07 - 15.53
Market cap$1.0B
Employees3,800

Another profit measure, before interest, tax and non-cash costs: EBITDA.

The risks · The things to watch: it's a small-cap, so the share price can swing harder than the market.

Plain-English interpretation of our own screen data. Analysis, not advice.

Where & How to Trade

AVO trades on Nasdaq. As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.

The Dated Journal · Newest First, Never Edited

Every Entry, As Written

2026-11-15 Distribution $11.83 +1.5% Entry 15

The analysis reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved up 1.5% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is momentum reading neutral. Over the past year the shares are down 2%. Our forward projection puts the odds of a 10% gain over the next month near 20%. The street (4 analysts) rates it strong buy, with a mean price target of $16. Insiders have been net buyers over the past quarter.

2026-11-08 Distribution · changed $11.66 +1.4% Entry 14

The framework has shifted from markdown to distribution since the last review. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved up 1.4% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is momentum reading bearish. Over the past year the shares are down 2%. Our forward projection puts the odds of a 10% gain over the next month near 20%. The street (4 analysts) rates it strong buy, with a mean price target of $16. Insiders have been net buyers over the past quarter.

2026-11-01 Markdown · changed $11.50 -2.7% Entry 13

The framework has shifted from distribution to markdown since the last review. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 2.7% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it D, carrying a low risk profile. Technically it is momentum reading bearish. Over the past year the shares are down 2%. Our forward projection puts the odds of a 10% gain over the next month near 20%. The street (4 analysts) rates it strong buy, with a mean price target of $16. Insiders have been net buyers over the past quarter.

2026-10-25 Distribution $11.82 -2.2% Entry 12

The analysis reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 2.2% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is momentum reading bearish. Over the past year the shares are down 2%. Our forward projection puts the odds of a 10% gain over the next month near 20%. The street (4 analysts) rates it strong buy, with a mean price target of $16. Insiders have been net buyers over the past quarter.

2026-10-18 Distribution $12.08 -3.4% Entry 11

The analysis reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 3.4% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it D, carrying a low risk profile. Technically it is holding around 12% above its long-term trend line with momentum reading oversold. Over the past year the shares are down 2%. Our forward projection puts the odds of a 10% gain over the next month near 20%. The street (4 analysts) rates it strong buy, with a mean price target of $16. Insiders have been net buyers over the past quarter.

2026-10-11 Distribution · changed $12.51 -2.3% Entry 10

The framework has shifted from accumulation to distribution since the last review. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 2.3% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it D, carrying a low risk profile. Technically it is holding around 12% above its long-term trend line with momentum reading oversold. Over the past year the shares are down 2%. Our forward projection puts the odds of a 10% gain over the next month near 20%. The street (4 analysts) rates it strong buy, with a mean price target of $16. Insiders have been net buyers over the past quarter.

2026-10-02 Accumulation $12.80 -0.2% Entry 9

Our analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.2% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it D, carrying a low risk profile. Technically it is holding around 12% above its long-term trend line with momentum reading oversold. Over the past year the shares are down 2%. Our forward projection puts the odds of a 10% gain over the next month near 20%. The street (4 analysts) rates it strong buy, with a mean price target of $16. Insiders have been net buyers over the past quarter.

2026-09-08 Accumulation $12.82 +0.0% Entry 8

Our analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it D, carrying a low risk profile. Technically it is holding around 12% above its long-term trend line with momentum reading oversold. Over the past year the shares are down 2%. Our forward projection puts the odds of a 10% gain over the next month near 20%. The street (4 analysts) rates it strong buy, with a mean price target of $16. Insiders have been net buyers over the past quarter. It reported earnings in this window, a natural checkpoint for the thesis.

2026-09-06 Accumulation $12.82 +0.0% Entry 7

Our analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it D, carrying a low risk profile. Technically it is holding around 12% above its long-term trend line with momentum reading oversold. Over the past year the shares are down 2%. Our forward projection puts the odds of a 10% gain over the next month near 20%. The street (4 analysts) rates it strong buy, with a mean price target of $16. Insiders have been net buyers over the past quarter. It reported earnings in this window, a natural checkpoint for the thesis.

2026-09-05 Accumulation · changed $12.82 -1.6% Entry 6

The framework has shifted from markup to accumulation since the last review. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 1.6% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it D, carrying a low risk profile. Technically it is holding around 12% above its long-term trend line with momentum reading oversold. Over the past year the shares are down 2%. Our forward projection puts the odds of a 10% gain over the next month near 20%. The street (4 analysts) rates it strong buy, with a mean price target of $16. Insiders have been net buyers over the past quarter. It reported earnings in this window, a natural checkpoint for the thesis.

Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.

Latest News · What the Market Is Reading on AVO

Headlines from third-party outlets, linked for reference: not our reporting, not advice.

Related Securities · Others in AVO's Space

Screened names in the same industry · explore each on its own page.

The Insider Ledger · Form 4 Filings, As Filed
Most recent filings · AVO
DateInsiderTitleTypeSharesValue
2026-10-09 Gonzalez Luis A Dir P - Purchase 52,022 $594,785
2026-09-24 Barnard Stephen J Exec COB S - Sale 21,646 $281,398
2026-06-30 Pack Jay A Dir Purchase 40,000 $2

Public filings, recorded as found. The full tape lives at Insider Intelligence.

The Political Ledger · Congressional Disclosures
Disclosures naming AVO
DatePoliticianPartyTypeAmount
2026-10-13 Ro Khanna Democrat sell 1K–15K
2026-04-13 Ro Khanna Democrat Purchase 1K–15K
2026-03-30 Alan Armstrong Republican buy 1K–15K
What Holding Actually Paid · Price Plus Dividends
If $1,000 had been placed · historical, not a promise
PeriodPrice thenPrice returnDivs per share$1,000 becameTotal return
1 month $12.72 -11.7% · $883 -11.7%
2 months $14.81 -24.2% · $758 -24.2%
3 months $13.23 -15.1% · $849 -15.1%
6 months $12.59 -10.8% · $892 -10.8%
1 year $11.50 -2.4% · $977 -2.4%
2 years $10.53 +6.7% · $1,067 +6.7%
3 years $13.40 -16.2% · $838 -16.2%
5 years $22.69 -50.5% · $495 -50.5%

Historical returns from market close data. Past performance does not guarantee future results.

The Ledger's Promise

This entry now belongs to the ledger. Whatever AVO does next, these words stay.

Mission Produce, Inc. · AVO · Distribution · $11.83
Recorded 2026-11-13 · before the outcome · scored mechanically

Membership

Thirteen thousand names carry this page. One desk keeps them honest.

Membership opens the full screen archive, the composites built from it, and the daily coverage that prices what the screen approves.

Join the desk

Screening is research, not a fatwa and not financial advice. Figures are drawn from public accounts at the screen date shown. Always manage your risk.

Get our weekly market brief free.